Skip to Late-Breaking Abstracts »
All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).
Abstract Titles
Poster Presentation Dates
All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.
Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.
| # | Type | Title | Authors | Category | Keywords |
|---|---|---|---|---|---|
| 670 | Poster Presentation | Develop a Multiplex Immunofluorescence Panel to Identification of distinct complex immune landscapes in pleural effusion liquids from patients with metastatic lung adenocarcinoma | Caddie Laberiano, MD; Luisa Solis, MD; Sinchita Roy Chowdhuri; Edwin R. Parra, MD, PhD; Caddie Laberiano, MD; | Microbiome and other environmental factors | Antibody; Biomarkers; Immune contexture; Tumor microenvironment |
| 671 | Poster Presentation | Update of a systematic review and meta-analysis studying the association between antibiotic use and clinical outcomes of non-small-cell lung cancer patients treated with immune checkpoint inhibitors | Pierre-Alain Bandinelli, MSc; Julie Cervesi; Clément Le Bescop; Renaud Buffet; Jean De Gunzburg; Gérard Zalcman; Pierre-Alain Bandinelli; | Microbiome and other environmental factors | Autoimmunity; Checkpoint blockade; Microbiome; Solid tumors |
| 672 | Oral Presentation | Identification of microbial-derived HLA-bound peptides in melanoma | Adi Nagler, MSc; Shelly Kalaora; Deborah Gitta Rosenberg; Michal Alon; Eilon Barnea; Ronen Levy; Kevin Vervier; Sophie Trabish; Tali Dadosh; Smadar Zaidman; Leore Geller; Polina Greenberg; Neerupma Bhardwaj; Alexandre Reuben; Reetakshi Arora; Michal Lotem; Arie Admon; Yishai Levin; Trevor Lawley; David Adams; Naama Geva-Zatorsky; Jennifer A. Wargo, MD, MMSc; Ravid Straussman; Yardena Samuels; | Microbiome and other environmental factors | Antigen presenting cells; Bioinformatics; Checkpoint blockade; Microbiome; Neoantigens; Proteomics; T cell; Tumor antigens; Tumor infiltrating lymphocytes (TILs); Vaccine |
| 673 | Poster Presentation | Precision microbiome mapping identifies a microbiome signature predictive of Immune Checkpoint Inhibitor response across multiple research study cohorts | Matthew J. Robinson, PhD; Kevin Vervier; Simon R. Harris; David Adams; Doreen Milne; Catherine Booth; Emily Barker; Christine Parkinson; David Bruce; Sarah Welesh; Pippa Corrie, PhD, BMBCh, FRCP; Trevor D. Lawley; | Microbiome and other environmental factors | Bioinformatics; Biomarkers; Checkpoint blockade; Microbiome |
| 674 | Poster Presentation | Late antibiotic administration during durvalumab treatment may be associated with clinical benefit | Siddharth Sheth, DO MPH; Christopher A. Morehouse, MD; Elizabeth A. Dozier; Chen Gao; Paul Warrener; Vancheswaran Gopalakrishnan, PhD, MPH, BDS; Scott Hammond, PhD; Taylor Cohen; Bret Sellman; | Microbiome and other environmental factors | Checkpoint blockade; Microbiome; Solid tumors |
| 675 | Poster Presentation | Oxygen concentration alters Natural Killer cell phenotype and function in the solid tumor microenvironment | Upasana Sunil Arvindam, MSc; Phillipa Kennedy; Brianna Ettestad; Peter Hinderlie; Gwen Phung; James Lim; Jeff S. Miller, MD; Martin S. Felices; | Microbiome and other environmental factors | Adoptive immunotherapy; Immune suppression; Metabolism; NK/NK T cell; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment |
| 676 | Poster Presentation | PD-L1 is induced by the periodontal pathogen Porphyromonas gingivalis and can be blocked by small molecule gingipain inhibitors, including atuzaginstat | Shirin Arastu-Kapur; Mai Nguyen; Sean Broce; Joseph P. Vacca; Kirk Ehmsen; Florian Ermini; Ursula L. Haditsch; Aurora Martinez-Horta; Debasish Raha; Leonardo Rodriguez; Casey Lynch; Stephen S. Dominy; Leslie J. Holsinger; | Microbiome and other environmental factors | Checkpoint blockade; Coinhibition; Immune suppression; Inflammation; Microbiome; Monocyte/Macrophage; Solid tumors; Targeted therapy; Tumor evasion; Tumor microenvironment |
| 677 | Poster Presentation | Evaluation of anti-PD1 efficacy in germ-free and antibiotic-treated SPF mice bearing MC38 tumors | Ying Jin; Xue Liang; Frieda Z. Zhang; Guangmao Mu; Wei Zhou; Annie X. An; Marvin Y. Ouyang; Cai Li; Andy Liaw; Henry Q. Li; Davy X. Ouyang, PhD; | Microbiome and other environmental factors | Checkpoint blockade; Microbiome |
| 678 | Poster Presentation | Addition of a single bacteria facilitates anti-tumor immunity and long-term survival in colorectal cancer. | Abigail E. Overacre-Delgoffe, PhD; Anthony R. Cillo, PhD; Hannah J. Bumgarner, BS; Ansen Burr; Justin Tometich; Amrita Bhattacharjee; Tullia C. Bruno, PhD; Dario A. Vignali, PhD; Timothy W. Hand; | Microbiome and other environmental factors | Dendritic cell; Microbiome; T cell; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment |
| 679 | Poster Presentation | High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors | Corentin Richard, PhD; Myriam Benlaifaoui; Omar El Ouarzadi; Khoudia Diop; Antoine Desilets; Julie Malo; Wiam Belkaid; Andréanne Leblanc; Julien Lamontagne; Meriem Messaoudene; Arielle Elkrief; Bertrand Routy; | Microbiome and other environmental factors | Bioinformatics; Checkpoint blockade; Gene expression; Microbiome; Tumor microenvironment |
| 680 | Poster Presentation | Automated Ion Torrent based solution enables accurate gut microbiome quantification of bacterial species relevant to research in cancer and its response to immunotherapy | Shrutii Sarda, PhD; David Merrill, PhD; Heesun Shin; Anna McGeachy, PhD; Birgit Drews; Wing Lee; Rajesh K. Gottimukkala, MS; Janice K. Au-Young, PhD; Fiona Hyland; Shrutii Sarda, PhD; | Microbiome and other environmental factors | Autoimmunity; Bioinformatics; Microbiome |
| 681 | Poster Presentation | Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors | Fyza Y. Shaikh, MD, PhD; James R. White, PhD; Joell J. Gills, PhD; Taiki Hakozaki; Richard Corentin; Bertrand Routy; Yusuke Okuma; Mykhaylo Usyk; Abhishek Pandey; Jeffrey S. Weber, MD, PhD; Jiyoung Ahn; Jarushka Naidoo, MB BCH MHS; Evan J. Lipson, MD; Drew M. Pardoll, MD, PhD; Cynthia Sears; | Microbiome and other environmental factors | Bioinformatics; Biomarkers; Checkpoint blockade; Microbiome; Solid tumors |
